Divi's Laboratories Ltd.

DIVISLAB

₹5563.35

-0.98% (-55.2)

Market Cap

₹1,49,254 Cr.

P/E

81.29

About

Divi's Laboratories Limited is a key player in the pharmaceutical industry, specializing in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. Th… Read more

Divi's Laboratories Limited is a key player in the pharmaceutical industry, specializing in th… Read more

Low

3350

52W Range

High

6285

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoters has been selling shares in the open market over last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has decreased over last 10 years more due to derating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Brand Wise Break-Up

Asset Break-Up

Operational Metrics

R&D as a % of Total Sales (%)
Source

Peer Comparison

Suppliers

Neogen Chemicals Ltd.
HLE Glascoat Ltd.
Tatva Chintan Pharma Chem Ltd.

FAQs on Divi's Laboratories Ltd. Business

What does Divi's Lab do?

Divi's Laboratories Limited is a global pharmaceutical company specializing in the manufacturing of API's, Intermediates, and Nutraceutical ingredients for exports. It also offers custom synthesis services to innovator pharma companies for their patented products.

Who are the competitors of Divi's Lab?

Divi's Lab major competitors are Laurus Labs, Neuland Laboratories, Alivus Life Sciences, Granules India, AMI Organics, Shilpa Medicare, Supriya Lifescience.
Market Cap of Divi's Lab is ₹1,49,254 Crs.
While the median market cap of its peers are ₹13,692 Crs.

Is Divi's Lab financially stable compared to its competitors?

Divi's Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini		Dec			Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec

Discussions & Analysis

Divi's Laboratories Ltd.

Divis: A Megacap Multibagger - SOIC

View the discussion on ValuePickr

Nutraceuticals- Industry Overview - Value Educator

Detailed Analysis Of Divi's Labs & Business Model - Value Educator

Detailed analysis on Divi’s Laboratories - A Mega Cap Compounding Machine - Value Educator

Divi's In A Nutshell - Harsh Doshi

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Phama Industry - Terminologies and Value Chain - Alpha Invesco

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Divi's Laboratories Ltd.